Presentation is loading. Please wait.

Presentation is loading. Please wait.

Comparative Analysis of Persistence to Treatment among Patients with Asthma or COPD Receiving AirFluSal Forspiro or Seretide Diskus Salmeterol/Fluticasone.

Similar presentations


Presentation on theme: "Comparative Analysis of Persistence to Treatment among Patients with Asthma or COPD Receiving AirFluSal Forspiro or Seretide Diskus Salmeterol/Fluticasone."— Presentation transcript:

1 Comparative Analysis of Persistence to Treatment among Patients with Asthma or COPD Receiving AirFluSal Forspiro or Seretide Diskus Salmeterol/Fluticasone Propionate Combination Therapy  Bruce G. Bender, PhD, Ramon A. Hernandez Vecino, PhD, Kevin McGrath, MSc, Spencer Jones, PhD  The Journal of Allergy and Clinical Immunology: In Practice  Volume 4, Issue 5, Pages (September 2016) DOI: /j.jaip Copyright © 2016 The Authors Terms and Conditions

2 Figure 1 Kaplan-Meier survival (persistence) curve. The survival probability estimates at 12 months were (0.02 standard error) for AirFluSal Forspiro versus (0.025 standard error) for Seretide Diskus. The Journal of Allergy and Clinical Immunology: In Practice 2016 4, DOI: ( /j.jaip ) Copyright © 2016 The Authors Terms and Conditions


Download ppt "Comparative Analysis of Persistence to Treatment among Patients with Asthma or COPD Receiving AirFluSal Forspiro or Seretide Diskus Salmeterol/Fluticasone."

Similar presentations


Ads by Google